New to The Street Broadcasts Episode 753 Featuring Virtuix Holdings Medicus Pharma YY Group Holding and FreeCast on Bloomberg Television Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook Charter Communications Proposes Enhanced Buyout of Liberty Broadband in Strategic Consolidation Fed Minutes Reveal Officials Anticipate Rate Hikes If Inflation Persists ATTs CEO Highlights BlueCollar Worker Demand as AI Economy Reshapes Labor Market RBI Approves ICICI Bank CEO Sandeep Bakhshis Reappointment for Two More Years PASG Q1 2026 Earnings Narrowerthanexpected loss lifts shares OPTU Q1 2026 Earnings Massive EPS Miss Sends Shares Lower ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns Remitly Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies Nexalin Technology Inc NXL Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Intensifies RD Spend Latham Group SWIM Q1 2026 Earnings EPS Surprise Drives Shares Higher Zhihu Inc ZH Tests Key Support Near 300 as Selling Pressure Continues SELLAS Life Sciences Group SLS Surges 629 as Biotech Momentum Builds Ichor Holdings ICHR Gains 139 as Shares Approach Resistance DTE Energy Junior Subordinated Debenture DTW Edges Higher in Quiet Trading Polaryx Therapeutics PLYX Slides 86 as Stock Tests Key Support Levels Roundhill Memory ETF Hits 10 Billion Milestone Fastest in ETF History Amid AI Chip Shortage Exicure Inc XCUR Q2 2022 Earnings WiderthanExpected Loss No Revenue Shares Edge Higher DTSTW Holds at 001 Data Storage Corporation Warrant Sees Minimal Movement XTKG Q4 2019 Earnings Massive EPS Miss Triggers 43 Stock Plunge ICON Q4 2025 Earnings EPS Misses Estimates as Loss Widens Shares Rise 075 Verizon Q1 2026 Earnings EPS Beat Encourages Revenue Details Remain Scarce PANL Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Headwinds MSEX Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Edges Higher SLDP Q1 2026 Earnings Solid Power Beats EPS Estimates by a Wide Margin PreRevenue Status Maintained VIR Q1 2026 Earnings Significant EPS Miss as Biotech Continues Investment Phase